TGF-βRI inhibitor 1

• UNSPSC Description:

  TGF-βRI inhibitor 1 (compoimd i) is a TGF-βRI inhibitor. TGF-βRI inhibitor 1 can be used for cancer research[1].

• Target Antigen:

  TGF-β Receptor

• Type:

  Reference compound

• Related Pathways:

  TGF-beta/Smad

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/tgf-βri-inhibitor-1.html

• Solubility:

  10 mM in DMSO

• Smiles:

  NC(/C=C/C1=C(C=CC2=NC=NN21)C3=C(CCC4)N4N=C3C5=CC=CC(C)=N5)=O

• Molecular Weight:

  385.42

• References & Citations:

  [1]Wu, et al. Crystal form and salt form of TGF- β RI inhibitor and preparation method thereof. Patent, CN111479809A.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2169299-67-4